Condition: Dravet Syndrome · Sponsor: Epygenix
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole hydrochloride (EPX-100) as adjunctive therapy in children and adult participants with Dravet syndrome (DS).
This description comes directly from the study's public registry record.
Krystle Rapchak · +1 (312) 847-1289 · clinicaltrials@harmonybiosciences.com
Eric Bauer · clinicaltrials@harmonybiosciences.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Active Not Recruiting |
| Arkansas Children's Hospital | Little Rock, Arkansas, United States | Active Not Recruiting |
| Children's Hospital of Los Angeles | Los Angeles, California, United States | Terminated |
| University of California Irvine | Orange, California, United States | Recruiting |
| UCSF Medical Center | San Francisco, California, United States | Recruiting |
| Yale University School of Medicine | New Haven, Connecticut, United States | Not Yet Recruiting |
| Yale School of Medicine - Yale-New Haven Hospital | New Haven, Connecticut, United States | Recruiting |
| The Nemours Foundation | Wilmington, Delaware, United States | Terminated |
| Rare Disease Research FL | Kissimmee, Florida, United States | Recruiting |
| Pediatric Neurology and Epilepsy Specialists | Winter Park, Florida, United States | Recruiting |
| Clinical Integrative Research Center of Atlanta (CIRCA) | Atlanta, Georgia, United States | Withdrawn |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Terminated |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04462770